Preclinical studies suggest that inhibition of both MDM2 and MDM4 may stabilize p53 in leukemic cells;32 however, no clinical data for dual inhibition of MDM2/MDM4 in AML patients have been published. The gene discussed is MDM4; the disease is acute myeloid leukemia.